How Calvin Johnson Turned an NFL Pain Story Into a Cannabis Company

Two former Detroit Lions built a multistate cannabis operator around injury, opioids and stigma, and in 2026 bet its future on Michigan cultivation.

By Cannible Editorial

Calvin Johnson and Rob Sims, former Detroit Lions teammates, co-founded Primitiv, a vertically integrated cannabis company operating in Michigan and Massachusetts. Johnson built the brand around his own experience with pain, his frustration with opioid prescribing in professional football, and the stigma he grew up around. In 2026 the company announced a return to premium Michigan cultivation under a signature Hall of Fame genetics line. The practical upshot for you: the founder story is specific and documented, but it is testimony, not clinical proof that cannabis treats football injuries, so judge the products the way you would judge any brand, on lab results and repeat purchases.

Here is the short version before the detail.

This article is general information about a cannabis business and the surrounding policy landscape. It is not medical or legal advice. Cannabis laws differ by state, and decisions about pain or recovery should be made with a healthcare provider familiar with your situation.

Primitiv Group: Hall of Fame genetics announcement — The 2026 company announcement of a return to premium Michigan cultivation.

From Detroit Lions teammates to co-founders

Johnson and Sims played on the same offensive unit in Detroit. Johnson spent nine seasons as one of the most productive receivers in NFL history. Sims protected quarterbacks as a guard. Both walked away from the game with accumulated damage and a shared skepticism about how the league handled pain.

Their transition into cannabis ran through real estate first. Johnson's property work served as a springboard, allowing the pair to secure several cannabis-approved sites for development before launching the brand itself. He has since been named to two cannabis 40 under 40 lists by Marijuana Ventures and Cannabis Now.

The company lays out its founding logic plainly on its own site: in professional football, players are often prescribed opioid painkillers for treatment, which can lead to dependency and addiction. Johnson has described the same frustration in interviews about starting the business.

The published research supports the concern. In a study of former NFL players, 52% reported opioid use during their careers, and 71% of those reported misusing them. That is not a fringe finding, and it is the backdrop against which Primitiv was built.

How pain changed Johnson's view of cannabis

As the injuries piled up, Johnson's relationship with cannabis changed. What he once kept quiet became, in his own telling, part of how he survived nine seasons of professional football.

He chose the sport's biggest stage to say so. At his 2021 Hall of Fame induction, Johnson openly credited a primitive and healing plant with helping him get through his career. Observers called it stunning, and it was, given the league's historically hardline stance on cannabis.

No independent clinical evidence establishes that cannabis treated or cured Johnson's injuries. He has never claimed that either, and neither should anyone retelling his story. What he describes is his own recovery routine and his own outcome. That is the appropriate frame.

His experience is real. The science on cannabis for sports recovery is still incomplete. Both are true, and keeping them separate is the whole point of covering a story like this properly.

The stigma was personal, and the enforcement was unequal

Johnson has talked openly about the negative attitudes toward cannabis he grew up with in his own family and community. That stigma was not just cultural. It had a legal structure behind it, and the enforcement never fell evenly.

Black people remain 3.64 times more likely to be arrested for marijuana possession than white people nationwide, despite similar usage rates across racial groups.

Research from Weill Cornell Medicine, analyzing 11 states over 13 years, is more specific about what legalization did and did not change.

Legalization changed the numbers. The disparity held. That is a population-level observational finding, and it describes what happened rather than proving why.

Johnson's story sits inside that history. It does not represent every athlete or every Black family's experience. Treating one founder's story as universal would flatten something that deserves more care. What his story does show is why a Black former athlete building a licensed cannabis business in Michigan carries meaning beyond the bottom line.

What Primitiv actually operates

A lot of famous names attach themselves to cannabis brands without much more than a signature on a licensing deal. Johnson and Sims took a different route: ownership and operations.

Here is what the company's documented footprint looks like.

A quick note on terms: water-soluble cannabinoids are cannabis compounds processed to mix into liquids, used in beverage-style and wellness products.

Everything above comes from company statements and trade coverage. Revenue figures, market share, and independent product verification are not in the public record, so an honest profile leaves those blank.

The 2026 return to Michigan cultivation

In 2026, Primitiv announced what it described as a pivotal return to its roots, debuting a signature line of Hall of Fame genetics grown in Michigan.

Not an expansion, it's a return to the group's foundation of elite cultivation.

Rob Sims, Primitiv co-founder, 2026 announcement

After years of expanding into retail, products, and a multistate footprint, the founders are now staking their long-term identity on one thing: growing the plant well. That is a real bet, and it narrows the brand's identity on purpose.

An announcement proves intent. Words like premium, quality and elite in that announcement belong to the company. Proof of product performance and consumer demand comes later, on shelves and in repeat purchases. At Cannible we treat those claims the way we treat any brand's claims: attributed first, then tested against what the market actually shows.

What athlete-founded cannabis brands have to prove

Primitiv is operating inside a fast-growing category. Al Harrington's Viola generated roughly $20 million in revenue across five states while actively working to help Black and Brown entrepreneurs build a foothold in the industry. Mike Tyson, Marshawn Lynch, Ricky Williams, and Megan Rapinoe all run or back athlete-founded brands.

A credible founder story gets people through the door. What actually keeps the lights on is cultivation quality, compliance, and the ability to survive a bad quarter.

The difference between endorsement and operation

An endorsement puts a face on someone else's product. Operational involvement means owning licenses, managing compliance, hiring cultivation teams, and absorbing the financial risk when a harvest fails or a regulation shifts.

Primitiv's documented structure, with vertical integration and the founders in active operating roles, points toward that second model. That is a harder road than an endorsement deal, and the upside is proportional.

What durable brands demonstrate over time

Three things separate lasting cannabis companies from famous ones.

This is category analysis, offered as a framework for evaluating any athlete brand. It is not a verdict on Primitiv. The public record simply does not contain the audited numbers a verdict would require.

How the NFL's own rules have shifted

Johnson mentioned cannabis at his 2021 induction. The league he spent his career in has shifted considerably since then, and the direction is worth understanding.

In December 2024, the NFL raised its THC testing threshold from 150 ng/ml to 350 ng/ml and cut first-offense penalties from a half-game suspension to a $15,000 fine. That built on 2020 reforms that ended suspensions for cannabis entirely and limited testing to a narrow training-camp window.

Player behavior had already outpaced the rulebook for years before those changes. Travis Kelce estimated that 50 to 80% of NFL players use cannabis, mainly for pain management and recovery. That is an informed guess from inside a locker room, not a survey, and it deserves that label.

Policy changes, player accounts, and businesses like Primitiv all point the same way: cannabis in professional sports is becoming an open conversation about recovery. That conversation still requires evidence. League rules describe what is permitted. Medical research describes what works. Neither substitutes for the other.

Frequently asked questions

What cannabis company did Calvin Johnson start?

Johnson co-founded Primitiv, a vertically integrated cannabis company with cultivation in Michigan, dispensaries in Niles, Michigan and Boston, Massachusetts, and product lines including Primitiv, Turf, and Primitiv Performance.

Who founded Primitiv with him?

Rob Sims, his former Detroit Lions teammate and an ex-NFL guard, co-founded the company and remains active in its leadership and public communications.

Why did Johnson enter the cannabis industry?

He cites his personal experience using cannabis to cope with football injuries, concern about opioid prescribing in professional sports, and a desire to challenge stigma he encountered in his own family and community. His real estate work provided the entry point for securing licensed sites.

Does Primitiv still operate?

Yes. The company announced a renewed focus on premium Michigan cultivation in 2026, framed by Sims as a return to its foundation in elite growing.

Is cannabis proven to treat football injuries?

No. Johnson's account is personal testimony, and no independent clinical evidence establishes cannabis as a proven treatment for football injuries. Anyone considering cannabis for pain should talk with a healthcare provider familiar with their situation.

Key takeaways

The Cannible Newsroom's take

If a friend asked us about Primitiv, we would say the story holds up because it is specific. Real injuries, real stigma, actual licenses in two states. That is more than most celebrity cannabis ventures can show, and the decision to own cultivation rather than rent out a name is the part we find most credible.

What concerns us is the gap between a good story and a verified business. Nobody outside the company can see revenue, margins, or repeat purchase rates, and the language in the 2026 announcement, premium, elite, quality, is marketing until a lab result and a shelf say otherwise. We would rather wait for those than grade the company on its founders' reputations.

The nuance we keep coming back to is the evidence line. Johnson never claimed cannabis cured him, and the retelling of his story should not either. The research on cannabis for pain and athletic recovery is still limited and largely observational. The enforcement data, by contrast, is unambiguous and worth sitting with: legalization cut arrests for everyone and still left Black Americans arrested at a far higher rate.

We will update this article as the law, the data, or the science changes.

Sources and further reading

For questions about legal cannabis use where you live, check your state regulator's current rules, and speak with a licensed healthcare provider before using cannabis for pain or recovery.

Find the shelf before you judge the brand

Founder stories are a starting point. What you can actually verify is the product in front of you and the shop that sells it.

View on Cannible →